Having trouble viewing this email? View in your browser.

31 July 2018

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


ESCMID/ASM Conference on Drug Development: CME and Poster Update

The Poster Programme has been released for the “ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance”, and can be viewed on the conference website. Furthermore, the conference has been accredited by EACCME® with up to 24 European CME Points.

Registrations still available!

› Read more

ESCMID and JAID signed a Memorandum of Understanding

ESCMID and the Japanese Association for Infectious Diseases (JAID) signed a Memorandum of Understanding to affirm their will to increase collaborative relationships and to strengthen practice, education and advocacy of science. JAID was established in 1926, currently numbers 11’000 members and is active on a variety of issues associated with infectious diseases, locally and globally. ESCMID and JAID envision to co-sponsor educational sessions or workshops at international meetings, to co-develop continuing education program and webinar, and to collaborate on joint projects. By signing this memorandum, JAID joins the large family of ESCMID international partners, which also includes since April 2018 the Korean Society of Laboratory Medicine (KSLM).

› Read more

2018 CRACK IT Challenges

The UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) will launch in September the CRACK IT Challenges, a research competition to solve scientific and business problems identified by the bioscience sector. The Challenges are designed to reduce the reliance on animal models and/or improve animal welfare and lead to the development of marketable products. This year, one of the challenges aims at developing  an immunologically-competent liver model to assess attenuation of yellow fever vaccines. The competition is open to any European Union (EU) body, public or private. Applications can be from single organizations or investigators or from consortia. The lead applicant must be EU based.

› Read more

ESCMID Postgraduate Course on Antifungal Resistance in Candida and Aspergillus

Make sure not to miss your chance to enroll in the ESCMID Postgraduate Education Course “Antifungal Resistance in Candida and Aspergillus: from Clinic to Clinical Laboratory” in Delhi, India, 19-21 September 2018. Registrations close on the 17th of August, this is one course not to be missed!

› Read more

ISHLT call for abstracts opening 1st August 2108

The International Society of Heart and Lung Transplantation is seeking abstracts for its 39th Annual Meeting and Scientific Sessions, scheduled for April 3 - 6, 2019, in Orlando, Florida (USA) at the Loews Meeting Complex. ISHLT is particularly interested in abstracts related to Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Hypertension. The submission fee is $25. Abstract submission deadline is 23 October 2018.

› Read more

CMI highlight: Time to blood culture positivity independently predicts infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia

Siméon et al report the results of multicentre, prospective cohort study including 587 adult patients with S. aureus bacteraemia to study the association between time to blood culture positivity (TTP) and infective endocarditis (IE) or death.
The median TTP of first positive blood culture was 13.7 h (interquartile range, 9.9-18). On multivariate analysis, 30-day mortality was associated with TTP≤13.7 h (74/295 (25.1%) vs 47/292 (16.1%), P=0.02), as well as old age, the McCabe score, methicillin resistance, stroke, pneumonia, and C-Reactive Protein. TTP was also independently associated with IE, but with a U-shape curve, IE was more common in the first (TTP<10 h, 17/148, 11.5%), and the last (TTP>18 h, 8/146, 5.5%) quartiles of TTP (P=0.002).
In conclusion, TTP provides reliable information on the risk and prognosis of IE (short TTP being an independent predictor of death) and may be used to identify patients who require specific attention.

› Read more

Use the summer break to apply for a research grant!

Applications for next year’s ESCMID research grants are being accepted until 25 September 2018 at 12:00 noon CEST. This year, we accept proposals for projects focused on fungal/viral/parasitic infections and diseases (including diagnostics, pathogenesis, susceptibility, resistance, stewardship and vaccines).

In addition to the regular grants worth EUR 20,000, ESCMID has reserved up to EUR 50,000 each for two excellently rated projects.

For more information, have a look at the website or download all relevant information as one package.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.